PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
14.54%
Revenue growth 50-75% of CRWV's 23.55%. Martin Whitman would scrutinize if slower growth is temporary.
76.00%
Cost growth above 1.5x CRWV's 19.16%. Michael Burry would check for structural cost disadvantages.
14.04%
Gross profit growth 50-75% of CRWV's 25.15%. Martin Whitman would scrutinize competitive position.
-0.43%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
10.58%
R&D change of 10.58% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
11.92%
Operating expenses growth 50-75% of CRWV's 17.97%. Bruce Berkowitz would examine efficiency.
12.86%
Total costs growth 50-75% of CRWV's 18.28%. Bruce Berkowitz would examine efficiency.
No Data
No Data available this quarter, please select a different quarter.
17.98%
D&A growth 50-75% of CRWV's 26.15%. Bruce Berkowitz would examine asset strategy.
16.74%
EBITDA growth 50-75% of CRWV's 33.05%. Martin Whitman would scrutinize operations.
-15.25%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
16.54%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
1.75%
Operating margin growth below 50% of CRWV's 156.60%. Michael Burry would check for structural issues.
147.56%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
47.25%
Pre-tax income growth exceeding 1.5x CRWV's 9.63%. David Dodd would verify competitive advantages.
28.57%
Similar pre-tax margin growth to CRWV's 26.86%. Walter Schloss would investigate industry trends.
18.18%
Tax expense growth above 1.5x CRWV's 3.78%. Michael Burry would check for concerning trends.
70.89%
Net income growth exceeding 1.5x CRWV's 7.67%. David Dodd would verify competitive advantages.
49.20%
Net margin growth exceeding 1.5x CRWV's 25.27%. David Dodd would verify competitive advantages.
71.43%
EPS growth exceeding 1.5x CRWV's 23.08%. David Dodd would verify competitive advantages.
69.23%
Diluted EPS growth exceeding 1.5x CRWV's 23.08%. David Dodd would verify competitive advantages.
0.58%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
0.08%
Diluted share reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.